ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Comvest Partners Announces Structured Capital Investment in Apotheco Pharmacy Group

Comvest Partners (“Comvest”), an operationally focused middle-market private investment firm, is pleased to announce that Comvest Special Opportunities, Comvest’s structured capital investment platform, has completed a junior capital investment in Apotheco Pharmacy Group (“Apotheco”, or the “Company”), an operator of specialized pharmacies focused on clinical dermatology.

Comvest Special Opportunities also made an equity co-investment in the business that will be used to help fund Apotheco’s strategic acquisitions and other growth initiatives.

Founded in 2013, Apotheco provides specialized dermatological care solutions to medical providers and patients. The Company operates a growing pharmacy network that spans 15 states nationwide and is staffed by teams of dermatology specialists. Apotheco offers electronic prescriptions, a large inventory of dermatology medications, and free shipping. Conditions treated by Apotheco’s products include acne, rosacea, eczema, psoriasis, and skin infections and wounds.

“Comvest Special Opportunities’ financing solutions are well-suited for companies like Apotheco in fast-moving situations where the ability to quickly secure meaningful and targeted capital is critical to their next phase of growth,” said Derek Gould, a Managing Director at Comvest.

“Comvest executed a complex transaction in a challenging financing market and, through Comvest Special Opportunities’ flexible investment mandate, provided a hybrid capital solution to support Apotheco’s current and future needs,” said Tom Goila, a Partner of Comvest.

Comvest Special Opportunities provides capital solutions that can combine structured debt and non-control equity, offering a flexible investment approach to middle-market companies facing situational challenges that require creative financing to help achieve their strategic goals. Comvest is able to quickly execute complex transactions, typically involving a variety of unique growth and operational factors, and is comfortable with opaque and fast-moving situations in which there are a range of plausible valuations and outcomes.

About Apotheco Pharmacy Group

Apotheco is a leading clinically focused network of specialized pharmacies serving the dermatology market. Through its high-touch model, Apotheco benefits prescribers, patients and payors by providing convenience, cost savings and leading customer service. For more information, visit https://www.apothecopharmacy.com.

About Comvest Partners

Comvest is an operationally focused private investment firm that has provided equity and debt capital to well-positioned middle-market companies throughout North America since 2000. Through its private equity, direct lending and special opportunities investment platforms, Comvest offers tailored investment solutions across the capital structure, deep industry and operating expertise, a collaborative approach, and significant transaction experience as an active investor. Today, Comvest manages more than $9.3 billion in assets, and has invested over $11 billion since inception. Based in West Palm Beach, Comvest also maintains offices in Chicago and New York. For more information, please visit www.comvest.com.

“Comvest Special Opportunities’ financing solutions are well-suited for companies in fast-moving situations where the ability to quickly secure meaningful and targeted capital is critical to their next phase of growth."

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  226.97
+2.76 (1.23%)
AAPL  268.81
+5.99 (2.28%)
AMD  259.67
+6.75 (2.67%)
BAC  53.02
+0.45 (0.86%)
GOOG  269.93
+9.42 (3.62%)
META  750.82
+12.46 (1.69%)
MSFT  531.52
+7.91 (1.51%)
NVDA  191.49
+5.23 (2.81%)
ORCL  281.40
-1.93 (-0.68%)
TSLA  452.42
+18.70 (4.31%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.